About Celldex (CLDX)
Celldex Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of several immunotherapy technologies for the treatment of cancer and other diseases. Its lead drug Rintega (also referred to a... Read more
- USD18.20
- USD20.08
- USD18.20
- USD47.00
- 11.70%
- 7M
- 1.00M
- 702.38k
- 1.4B
- 14.40
- -55.40%
Stock News
2 hours ago
Stock-market bulls face inflation test this week, but trade talks may set the tone
MarketWatch
5 hours ago
Adtalem Global Education: A Picks-And-Shovels Play On The U.S. Healthcare Labor Crisis
SeekingAlpha
5 hours ago
The Real Brokerage Inc. 2025 Q1 - Results - Earnings Call Presentation
SeekingAlpha
6 hours ago
Invesco Rising Dividends Fund Q1 2025 Commentary
SeekingAlpha
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
